Reported 0 shares, down 200,000 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-06-30 | 826000 |
| 2025-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
Who else reported the position
97 managers reported BIOAGE LABS INC for Q3 2025.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| AH Capital Management L L C | Unchanged | 3,233,170 | 0 | 1.36% | $19,011,040 | 5 qtrs |
| Sofinnova Investments Inc | Reduced | 2,293,788 | -11,113 | 0.74% | $13,487,473 | 5 qtrs |
| Cormorant Asset Management LP | Unchanged | 2,140,605 | 0 | 0.87% | $12,586,757 | 5 qtrs |
| ADAR1 Capital Management LLC | Reduced | 1,880,073 | -57,050 | 1.04% | $11,054,829 | 4 qtrs |
| VANGUARD GROUP INC | Added | 1,651,247 | +93,694 | < 0.01% | $9,709,331 | 5 qtrs |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 1,600,000 | 0 | 0.36% | $9,408,000 | 4 qtrs |
| BlackRock Inc | Reduced | 1,279,621 | -7,796 | < 0.01% | $7,524,172 | 4 qtrs |
| ORBIMED ADVISORS LLC | Reduced | 790,901 | -131,058 | 0.11% | $4,650,498 | 5 qtrs |
| Sands Capital Ventures LLC | Unchanged | 786,353 | 0 | 1.01% | $4,623,756 | 5 qtrs |
| Pivotal bioVenture Partners Investment Advisor LLC | Unchanged | 653,374 | 0 | 2.22% | $3,841,839 | 5 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2025
- Filed
- November 14, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.